Advances in HIV-1-specific chimeric antigen receptor cells to target the HIV-1 reservoir

Antiretroviral therapy (ART) for HIV-1 has dramatically improved outcomes for people living with HIV-1 but requires life-long adherence and can be associated with short and long-term toxicity. Numerous pre-clinical and clinical investigations are underway to develop therapies for immune control of H...

Descripción completa

Detalles Bibliográficos
Autores principales: Choudhary, Madhu C., Cyktor, Joshua C., Riddler, Sharon A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241028/
https://www.ncbi.nlm.nih.gov/pubmed/35784676
http://dx.doi.org/10.1016/j.jve.2022.100073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241028/
https://www.ncbi.nlm.nih.gov/pubmed/35784676
http://dx.doi.org/10.1016/j.jve.2022.100073

Ejemplares similares